Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 1, 2006, Pages 46-51

  Hamzavi, Iltefat ^a,c   Shiff, Natalie ^a   Martinka, Magda ^a   Huang, Zhiwei ^a   McLean, David ^a   Zeng, Haishan ^a   Lui, Harvey ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 amino salicylic acid; Blue vitiligo; Dermal melanin; Melanin; Mesalazine; Phototoxicity; Spectroscopy

Indexed keywords

ALLOPURINOL; HEMOGLOBIN; MELANIN; MESALAZINE; METHOXSALEN;

ADULT; ARTICLE; CASE REPORT; CORRELATION FUNCTION; DEPIGMENTATION; ELECTRON MICROSCOPY; ERYTHEMA; FLUORESCENCE SPECTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUVA; REFLECTOMETRY; SKIN PIGMENTATION; SKIN PRURITUS; TISSUE DISTRIBUTION; ULTRAVIOLET B RADIATION; VITILIGO;

HUMANS; MALE; MELANINS; MIDDLE AGED; SPECTRUM ANALYSIS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 33646693659     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00195.x     Document Type: Article

References (11)

1. Freedberg IM, Fitzpatrick TB. Circumscribed melanocytopenic hypomelanoses attributed to heritable/congenital factors: Vitiligo. In: Fitzpatrick TB, ed. Fitzpatrick's dermatology in general medicine; Vol 1, 5th edn. New York: Health Professions Division, McGraw-Hill, 1999; 949 -960.
2. Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol 2000; 42: 589-596.
3. Ivker R, Goldaber M, Buchness MR. Blue vitiligo. J Am Acad Dermatol 1994; 30 (5 Part 2): 829-831.
4. Kienle A, Lilge L, Vitkin A, et al. Why do veins appear blue? A new look at an old question. Appl Opt 1996; 35: 1151-1160.
5. Kollias N, Baqer A. Spectroscopic characteristics of human melanin in vivo. J Invest Dermatol 1985; 85: 38-42.
6. Horiuchi Y, Shimakura S. Mesalazine and photosensitivity (letter). Am J Gastroenterol 1999; 94: 3386-3387.
7. Zeng H, MacAulay C, McLean DI, Lui H, Palcic B. Miniature spectrometer and multi-spectral imager as a potential diagnostic aid for dermatology. SPIE 1995; 387: 57-61.
8. Honigsmann H, Szeimies R-M, Knobler R, Fitzpatrick TB, Pathak M, Wolff K. Photochemotherapy and photodynamic therapy. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's dermatology in general medicine; Vol 1, 5th edn. New York: Health Professions Division, McGraw-Hill, 1999; 2881.
9. Mosher D, Fitzpatrick TB, Ortonne J-P, Hori Y. Hypomelanoses and hypermelanoses. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's dermatology in general medicine; Vol 1, 5th edn. New York: Health Professions Division, McGraw-Hill, 1999; 997.
10. Lakowicz JR. Principles of fluorescence spectroscopy. New York: Plenum Press, 1983.
11. Zeng H, MacAulay C, McLean DI, Palcic B. Spectroscopic and microscopic characteristics of human skin autofluorescence emission. Photochem Photobiol 1995; 61: 639-645.